Additional Details
-
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis
Medstar Georgetown University HospitalWashington DC. 20007-2113 -
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis
University of Iowa Hospitals and ClinicsIowa City IA. 522242-1009 -
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis
University of Florida (UF) Health Shands HospitalGainesville FL. 32610 -
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis
Accellacare US Inc. of WilmingtonWilmington NC. 28401-7307 -
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis
Temple University Hospital (TUH) - Temple Lung Center (TLC)Philadelphia PA. 19140-5103 -
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis
Local Institution - 0434Montreal QC. H2X 0C1 -
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis
The Ohio State University Wexner Medical CenterColumbus OH. 43201 -
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis
The University of Alabama at BirminghamBirmingham AL. 35294 -
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis
Yale New Haven HospitalNew Haven CT. 06510 -
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis
University of Maryland - Marlene and Stewart Greenebaum Cancer CenterBaltimore MD. 21201-1544 -
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis
Rush University Medical Center - Rush Pulmonary and Critical Care Medicine - Professional BuildingChicago IL. 60612-3841 -
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis
Massachusetts General HospitalBoston MA. 02114 -
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis
University of Colorado Anschutz Medical Campus - Department of Family MedicineAurora CO. 80045 -
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis
St. Joseph's Hospital and Medical CenterPhoenix AZ. 85013-4220 -
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis
UC Irvine Medical CenterOrange CA. 92868-3201 -
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis
Infectious Disease Associates Of NW Ohio Inc - ToledoToledo OH. 43608-2669 -
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis
The Lung Research CenterChesterfield MO. 63017-3425 -
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis
Washington University School of Medicine in St. LouisSaint Louis MO. 63110-1010 -
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis
Western Washington Medical Group (WWMG) - Everett - Silver Lake Medical Center LocationEverett WA. 98208-6526 -
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis
Local Institution - 0217Sherbrooke QC. J1H 5N4